Literature DB >> 6494625

Xerotrachea and interstitial lung disease in primary Sjogren's syndrome.

S H Constantopoulos, A A Drosos, P J Maddison, H M Moutsopoulos.   

Abstract

22 patients with primary Sjogren's syndrome were prospectively studied for respiratory system involvement with clinical, roentgenological and functional parameters. 12 patients (55%) had respiratory manifestations. In 10/12 (83%), respiratory symptoms occurred before or concomitantly with the classical symptoms of Sjogren's syndrome. There were two distinct forms of respiratory involvement: xerotrachea, manifested by dry cough without other symptoms and negative roentgenological and functional evaluation and diffuse interstitial lung disease manifested by dyspnea with or without dry cough with bibasilar rales, compatible chest roentgenogram, restrictive pattern in spirometry and/or hypoxemia. Xerotrachea was more common in patients with glandular form of Sjogren's syndrome (3/10) and diffuse interstitial lung disease in patients with extraglandular form (6/12). None of the 22 patients had pleurisy or other forms of respiratory involvement. Antibodies to Ro (SSA) and La (SSB) antigens were more common in patients with the extraglandular form of the syndrome but did not correlate with diffuse interstitial lung disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6494625     DOI: 10.1159/000194703

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  6 in total

1.  Lymphocytic alveolitis: A surprising index of poor prognosis in patients with primary Sjogren's syndrome.

Authors:  Y A Dalavanga; P V Voulgari; A N Georgiadis; C Leontaridi; S Katsenos; M Vassiliou; A A Drosos; S H Constantopoulos
Journal:  Rheumatol Int       Date:  2005-12-13       Impact factor: 2.631

2.  Renal tubular acidosis in primary Sjögren's syndrome.

Authors:  K C Siamopoulos; M Elisaf; A A Drosos; A A Mavridis; H M Moutsopoulos
Journal:  Clin Rheumatol       Date:  1992-06       Impact factor: 2.980

3.  Pulmonary nodules as initial manifestation of primary Sjogren's syndrome.

Authors:  M A Reuss-Borst; U Hartmann
Journal:  Ann Rheum Dis       Date:  2006-05       Impact factor: 19.103

4.  Lung function in primary Sjögren's syndrome: a cross sectional and longitudinal study.

Authors:  C Kelly; P Gardiner; B Pal; I Griffiths
Journal:  Thorax       Date:  1991-03       Impact factor: 9.139

5.  A follow-up study of pulmonary function in patients with primary Sjögren's syndrome.

Authors:  M Linstow; N J Kriegbaum; V Backer; C Ulrik; P Oxholm
Journal:  Rheumatol Int       Date:  1990       Impact factor: 2.631

6.  Unexplained cough: it is time to rule out Sjogren's syndrome.

Authors:  Matthew Koslow; Shaye Kivity; Vicktoria Vishnevskia-Dai; Issahar Ben-Dov
Journal:  Clin Rheumatol       Date:  2018-01-31       Impact factor: 2.980

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.